Stockscreener 앱 받기
148.75
1.77%
2.58
Insmed Inc 주식(INSM)의 최신 뉴스
Will Insmed Incorporated outperform its industry peersProfit Target & Long-Term Safe Investment Plans - mfd.ru
Insmed To Present at March 2026 Investor Conferences - PR Newswire
Prospects for Insmed’s treprostinil palmitil as progressive pulmonary fibrosis treatment - The Pharma Letter
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
Possible Bearish Signals With Insmed Insiders Disposing Stock - Yahoo Finance
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 13,396 Shares of Stock - MarketBeat
Profund Advisors LLC Cuts Stock Holdings in Insmed, Inc. $INSM - MarketBeat
ING Groep NV Makes New $53.79 Million Investment in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Fund Update: 43,686 INSMED (INSM) shares added to CIBC Asset Management Inc portfolio - Quiver Quantitative
Essex Investment Management Co. LLC Grows Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Candriam S.C.A. Has $57.26 Million Stock Position in Insmed, Inc. $INSM - MarketBeat
When Will Insmed Incorporated (NASDAQ:INSM) Become Profitable? - Yahoo Finance
Wellington Shields Capital Management LLC Invests $1.22 Million in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Insider Sell: Martina Flammer Sells Shares of Insmed Inc (INSM) - GuruFocus
Valuation Update: Is Insmed Incorporated stock a buy or sell2025 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn
Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 - Financial Times
C WorldWide Group Holding A S Sells 75,000 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) Insider Michael Alexander Smith Sells 640 Shares - MarketBeat
Insider Selling: Insmed (NASDAQ:INSM) COO Sells 791 Shares of Stock - MarketBeat
William Lewis Sells 3,009 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Truist Financial Corp Sells 7,420 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Lessened by WCM Investment Management LLC - MarketBeat
Insmed Presents Data on TPIP Inhalation Drug for PAH - respiratory-therapy.com
MACD Signal: What are the risks of holding Insmed Incorporated2025 Retail Activity & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Principal Financial Group Inc. Has $124.47 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Keybank National Association OH Has $2.41 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Mid-Cap Biopharmas Flex Their Commercial Muscle - Citeline News & Insights
Whale Trades: What are the risks of holding Insmed IncorporatedMarket Movement Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Y Intercept Hong Kong Ltd Decreases Position in Insmed, Inc. $INSM - MarketBeat
Rate Cut: Will Insmed Incorporated outperform its industry peers2025 Trading Volume Trends & Low Drawdown Trading Techniques - baoquankhu1.vn
Bank of New York Mellon Corp Trims Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed (INSM) Sees Surge in Bullish Option Activity - GuruFocus
Morgan Stanley Updates Rating for Insmed (INSM), Adjusts Price T - GuruFocus
New York State Common Retirement Fund Buys 18,123 Shares of Insmed, Inc. $INSM - MarketBeat
What Insmed (INSM)'s Upcoming TPIP Data and New Analyst Coverage Mean For Shareholders - Yahoo Finance
Insmed TPIP Data At PVRI 2026 Tests Pulmonary Arterial Hypertension Ambitions - Yahoo Finance
Insmed (NASDAQ:INSM) Coverage Initiated at Barclays - MarketBeat
Definium Therapeutics Appoints Roger Adsett To Board - citybiz
Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2025 - marketscreener.com
J. Safra Sarasin Holding AG Invests $1.09 Million in Insmed, Inc. $INSM - MarketBeat
Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire
Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed - Barchart.com
Barclays Initiates Coverage on Insmed With Overweight Rating, $231 Price Target - marketscreener.com
Barclays Initiates Coverage on Insmed (INSM) with Overweight Rat - GuruFocus
Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress - PR Newswire
EFG Asset Management North America Corp. Reduces Stake in Insmed, Inc. $INSM - MarketBeat
Mutual of America Capital Management LLC Lowers Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Strs Ohio Grows Stake in Insmed, Inc. $INSM - MarketBeat
Does Insmed Incorporated have strong fundamentalsJuly 2025 News Drivers & AI Based Buy and Sell Signals - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Trims Stake in Insmed, Inc. $INSM - MarketBeat
Setup Watch: What is ROIVs book value per shareWall Street Watch & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Insmed, Inc. $INSM Stock Holdings Lessened by Emerald Mutual Fund Advisers Trust - MarketBeat
Roth Capital Initiates Coverage of Insmed (INSM) with Buy Recommendation - Nasdaq
Stifel Initiates Insmed(INSM.US) With Buy Rating, Announces Target Price $212 - 富途资讯
Roth Capital Initiates Coverage on Insmed (INSM) with Buy Rating - GuruFocus
Roth/MKM initiates Insmed stock with Buy rating, $212 price target - Investing.com Canada
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock By Investing.com - Investing.com Nigeria
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock - Investing.com
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 10,699 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - PR Newswire
0.10%
0.10%
자본화:
|
볼륨(24시간):